Longitudinal effect of HCV cure on markers of kidney disease

Javier Cepeda1, Mohamed Atta2, Katie Zook2

  • 1Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland, United States of America.

Plos One
|June 11, 2025
PubMed

Insights

Curing chronic hepatitis C infection significantly improves kidney function, as measured by iohexol glomerular filtration rate (iGFR). Treatment attenuated kidney function decline, though it did not impact albuminuria levels.

Area of Science:

  • Nephrology
  • Hepatology
  • Infectious Diseases

Background:

  • Chronic hepatitis C (HCV) infection is associated with chronic kidney disease.
  • Direct-acting antiviral (DAA) treatments offer a cure for HCV but their long-term impact on kidney function requires further evaluation.
  • Iohexol glomerular filtration rate (iGFR) is a key marker for assessing kidney function.

Purpose of the Study:

  • To evaluate the impact of HCV cure on kidney function, specifically iGFR, in a cohort of patients with chronic HCV infection.
  • To assess the effect of HCV treatment on secondary outcomes like albuminuria.

Main Methods:

  • A cohort of 208 participants with chronic HCV infection (63% co-infected with HIV) was enrolled across two recruitment periods.
  • Linear mixed-effects modeling was used to analyze changes in iGFR slope between treated (cured) and untreated participants.
  • Albuminuria was assessed as a secondary outcome using the urine albumin-creatinine ratio (uACR).

Main Results:

  • HCV treatment was associated with a significantly higher iGFR slope (2.37 mL/min/1.73 m²/year) compared to untreated participants, indicating preserved kidney function.
  • While iGFR declined overall, the rate of decline was attenuated in participants who were cured of HCV.
  • HCV treatment status was not significantly associated with the probability of developing albuminuria.

Conclusions:

  • Achieving HCV cure through antiviral treatment has a significant positive impact on preserving kidney function over time.
  • HCV treatment may help attenuate the decline in kidney function observed in chronically infected individuals.
  • Further research may explore the mechanisms behind HCV cure's protective effect on kidney function and its impact on albuminuria.